An executive order on drug manufacturing, a controversial HHS appointee, a diabetes drug for prostate cancers, and more were this week’s top industry headlines.
Learn how molecular dynamics, AI-aided design, and structural insights combine to reshape how therapeutic proteins are created, validated, and optimized.